Last 7 days
-1.6%
Last 30 days
-9.0%
Last 90 days
-14.6%
Trailing 12 Months
30%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | 90,000 | cfo and evp |
2023-08-14 | Torres Kathryn A. | sold | -1,400,520 | 269 | -5,204 | svp-payer contracting & align. |
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | -40,500 | cfo and evp |
2023-08-14 | RUTHERFORD BILL B | gifted | - | - | -49,500 | cfo and evp |
2023-08-11 | Cohen Jeffrey E. | sold | -405,000 | 270 | -1,500 | svp-government relations |
2023-08-04 | Marks Mike A | gifted | - | - | -205 | svp-finance |
2023-08-03 | Marks Mike A | gifted | - | - | 8,343 | svp-finance |
2023-08-03 | Marks Mike A | gifted | - | - | -8,343 | svp-finance |
2023-08-03 | Whalen Kathleen M | sold | -787,320 | 270 | -2,916 | svp & chief ethics officer |
2023-08-02 | RUTHERFORD BILL B | gifted | - | - | -49,500 | cfo and evp |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | added | 88.67 | 4,828,230 | 9,368,880 | 0.08% |
2023-09-21 | Halpern Financial, Inc. | new | - | 28,831 | 28,831 | 0.01% |
2023-09-20 | BARCLAYS PLC | added | 135 | 85,095,000 | 134,746,000 | 0.09% |
2023-09-20 | Mondrian Investment Partners LTD | reduced | -10.05 | 4,678,210 | 137,307,000 | 2.74% |
2023-09-14 | IMS Capital Management | new | - | 203,332 | 203,332 | 0.11% |
2023-09-12 | Farther Finance Advisors, LLC | added | 2.61 | 14,612 | 95,305 | 0.02% |
2023-09-07 | ST GERMAIN D J CO INC | sold off | - | - | - | -% |
2023-09-05 | Westshore Wealth, LLC | reduced | -6.00 | 40,277 | 532,304 | 0.27% |
2023-09-01 | Manhattan West Asset Management, LLC | reduced | -0.95 | 34,999 | 284,968 | 0.11% |
2023-08-30 | Western Wealth Management, LLC | added | 0.85 | 139,121 | 1,004,830 | 0.09% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | frist thomas f jr | 24.5% | 69,391,032 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 2.5% | 7,039,050 | SC 13G/A | |
Feb 14, 2023 | hercules holding ii | 24.4% | 68,912,077 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 6.35% | 17,946,718 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.08% | 14,369,349 | SC 13G | |
Feb 01, 2023 | blackrock inc. | 5.2% | 14,839,215 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 6.7% | 21,128,934 | SC 13G/A | |
Feb 14, 2022 | hercules holding ii | 22.2% | 68,912,077 | SC 13G/A | |
Feb 14, 2022 | frist thomas f jr | 22.3% | 69,301,932 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 6.09% | 18,931,643 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 28, 2023 | S-8 | Employee Benefits Plan | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 15, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 11, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 07, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 68.9B | 61.9B | -8.98% | 30.00% | 11.93 | 1.11 | 3.02% | -11.37% |
LH | 18.2B | 14.1B | -4.55% | -3.42% | 21.91 | 1.29 | -5.68% | -58.27% |
DGX | 13.8B | 9.5B | -7.45% | 1.06% | 17.42 | 1.46 | -10.34% | -46.50% |
MID-CAP | ||||||||
DVA | 9.0B | 11.7B | -3.28% | 12.82% | 19.26 | 0.77 | 0.96% | -43.93% |
UHS | 8.9B | 13.8B | -2.67% | 35.75% | 12.86 | 0.65 | 5.76% | -10.75% |
EHC | 7.0B | 4.6B | 0.36% | 46.39% | 22.31 | 1.53 | 9.56% | -4.24% |
THC | 6.9B | 19.9B | -9.81% | 26.31% | 6.09 | 0.35 | 3.98% | -22.32% |
SGRY | 3.8B | 2.7B | -12.50% | 20.55% | -69.83 | 1.43 | 11.78% | -86.30% |
SEM | 3.3B | 6.5B | -8.71% | 10.65% | 16.25 | 0.51 | 3.35% | -11.85% |
SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -12.60% | 56.43% | -144.8 | 1.22 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.28% | -6.03% | 25.82 | 1.39 | 10.42% | 21.37% |
BKD | 803.8M | 3.0B | 0.71% | -13.03% | -7.8 | 0.27 | 11.66% | -12.20% |
CYH | 380.3M | 12.4B | -15.50% | 8.59% | 1.34 | 0.03 | -0.02% | 847.37% |
SSY | 6.1M | 46.8M | -7.45% | -15.53% | -2.24 | 0.13 | 12.07% | -154.21% |
20.3%
19.4%
14.4%
28.6%
46.5%
36.1%
18.5%
Y-axis is the maximum loss one would have experienced if HCA Healthcare was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 1.7% | 61,920 | 60,879 | 60,233 | 59,800 | 60,105 | 59,720 | 58,752 | 57,981 | 56,016 | 52,649 | 51,533 | 50,763 | 50,146 | 51,680 | 51,336 | 50,087 | 48,844 | 47,771 | 46,677 | 45,965 | 45,210 |
EBITDA | -100.0% | - | 13,493 | 13,290 | 12,497 | 13,869 | 14,152 | 14,252 | 13,657 | 11,453 | 10,877 | 9,735 | 9,357 | 9,364 | 9,036 | 9,664 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.22* | 0.22* | 0.21* | 0.23* | 0.24* | 0.24* | 0.24* | 0.20* | 0.21* | 0.19* | 0.18* | 0.19* | 0.17* | 0.19* | - | - | - | - | - | - |
Interest Expenses | 2.8% | 1,863 | 1,812 | 1,741 | 1,686 | 1,638 | 1,590 | 1,566 | 1,551 | 1,538 | 1,540 | 1,584 | 1,639 | 1,702 | 1,791 | 1,824 | 1,832 | 1,826 | 1,785 | 1,755 | 1,742 | 1,727 |
Earnings Before Taxes | 0.6% | 8,737 | 8,688 | 8,580 | 7,864 | 9,317 | 9,674 | 9,833 | 9,319 | 7,150 | 6,593 | 5,430 | 4,965 | 4,956 | 4,594 | 5,244 | 5,126 | 5,216 | 5,256 | 5,335 | 5,223 | 4,932 |
EBT Margin | -100.0% | - | 0.14* | 0.14* | 0.13* | 0.16* | 0.16* | 0.17* | 0.16* | 0.13* | 0.13* | 0.11* | 0.10* | 0.10* | 0.09* | 0.10* | - | - | - | - | - | - |
Net Income | 0.7% | 5,771 | 5,733 | 5,643 | 5,376 | 6,511 | 6,806 | 6,956 | 6,568 | 4,967 | 4,596 | 3,754 | 3,399 | 3,343 | 3,047 | 3,505 | 3,498 | 3,645 | 3,682 | 3,787 | 3,197 | 2,864 |
Net Income Margin | -100.0% | - | 0.09* | 0.09* | 0.09* | 0.11* | 0.11* | 0.12* | 0.11* | 0.09* | 0.09* | 0.07* | 0.07* | 0.07* | 0.06* | 0.07* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 4,249 | 4,127 | 4,174 | 3,673 | 4,532 | 5,382 | -200 | 640 | 7,209 | 6,397 | 11,959 | 10,718 | 3,773 | 3,444 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 1.7% | 53,594 | 52,711 | 52,438 | 51,484 | 51,584 | 52,208 | 50,742 | 49,562 | 48,164 | 47,277 | 47,490 | 51,016 | 48,709 | 45,421 | 45,058 | 43,912 | 45,449 | 43,379 | 39,207 | 38,044 | 37,742 |
Current Assets | 2.6% | 13,888 | 13,541 | 13,643 | 13,481 | 13,937 | 15,006 | 13,542 | 13,248 | 12,475 | 12,036 | 12,333 | 16,266 | 14,031 | 11,016 | 11,196 | 10,769 | 12,869 | 11,108 | 10,213 | 10,010 | 10,394 |
Cash Equivalents | 2.4% | 862 | 842 | 908 | 999 | 858 | 2,371 | 1,451 | 1,027 | 1,120 | 1,030 | 1,793 | 6,588 | 4,638 | 731 | 621 | 559 | 2,430 | 531 | 502 | 578 | 868 |
Inventory | -1.7% | 2,050 | 2,085 | 2,068 | 2,009 | 2,043 | 2,003 | 1,986 | 2,019 | 2,027 | 2,068 | 2,025 | 1,950 | 1,834 | 1,953 | 1,849 | 1,769 | 1,826 | 1,778 | 1,732 | 1,634 | 1,636 |
Net PPE | 2.3% | 26,644 | 26,053 | 25,575 | 24,978 | 24,587 | 24,228 | 24,063 | 23,547 | 23,471 | 23,188 | 23,199 | 22,941 | 23,071 | 22,985 | 22,715 | 22,002 | 21,467 | 21,128 | 19,757 | 19,041 | 18,544 |
Current Liabilities | 4.7% | 11,545 | 11,028 | 9,902 | 9,784 | 8,999 | 10,518 | 9,582 | 9,624 | 8,615 | 8,642 | 8,704 | 14,379 | 12,856 | 7,019 | 7,757 | 7,124 | 8,961 | 10,531 | 7,569 | 6,231 | 7,625 |
LT Debt, Current | 0.7% | 2,395 | 2,378 | 370 | 218 | 246 | 1,486 | 237 | 250 | 253 | 234 | 209 | 172 | 163 | 162 | 145 | 148 | 2,073 | 3,796 | 788 | 191 | 1,692 |
LT Debt, Non Current | 0.2% | 36,537 | 36,478 | 37,714 | 37,492 | 38,657 | 36,210 | 34,342 | 32,049 | 32,319 | 30,838 | 30,795 | 30,792 | 30,779 | 34,699 | 33,577 | 34,097 | 34,120 | 31,019 | 32,033 | 32,916 | 31,500 |
Shareholder's Equity | 98.7% | 461 | 232 | -73.00 | -778 | -1,142 | 414 | 1,489 | 1,825 | 1,790 | 2,482 | 2,892 | 1,299 | 568 | - | - | - | - | - | - | - | - |
Retained Earnings | 8.8% | -1,850 | -2,028 | -2,280 | -2,781 | -3,168 | -1,589 | -532 | -206 | -121 | 735 | 777 | -647 | -1,315 | -2,394 | -2,351 | -3,107 | -3,474 | -3,983 | -4,572 | -5,342 | -5,731 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | 294 | 185 | 88.00 | - | - | - | - | - | - | - | - |
Accumulated Depreciation | 2.1% | 30,023 | 29,410 | 29,182 | 28,752 | 28,229 | 27,814 | 27,287 | 27,148 | 27,227 | 26,689 | 26,118 | 25,834 | 25,413 | 24,876 | 24,520 | 24,293 | 23,902 | 23,455 | 23,208 | 22,937 | 22,598 |
Shares Outstanding | -1.1% | 273 | 276 | 277 | 284 | 293 | 302 | 305 | 318 | 328 | 338 | 339 | 338 | 338 | 338 | 338 | 341 | 342 | 343 | 343 | 346 | 349 |
Minority Interest | 1.4% | 2,764 | 2,727 | 2,694 | 2,592 | 2,538 | 2,447 | 2,422 | 2,520 | 2,383 | 2,235 | 2,320 | 2,273 | 2,354 | 2,259 | 2,243 | 2,118 | 2,132 | 2,099 | 2,032 | 1,875 | 1,864 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 9.4% | 9,825 | 8,980 | 8,522 | 8,438 | 7,695 | 8,316 | 8,959 | 2,933 | 3,373 | 9,845 | 9,232 | 15,320 | 14,729 | 8,003 | 7,602 | 7,272 | 6,867 | 6,452 | 6,761 | 6,320 | 5,607 |
Share Based Compensation | -8.7% | 303 | 332 | 341 | 357 | 385 | 429 | 440 | 474 | 440 | 377 | 362 | 313 | 337 | 367 | 347 | 327 | 292 | 270 | 268 | 279 | 264 |
Cashflow From Investing | -1.4% | -3,747 | -3,695 | -3,389 | -4,310 | -3,124 | -2,839 | -2,643 | -1,839 | -3,009 | -2,897 | -3,393 | -3,828 | -4,560 | -4,700 | -5,720 | -5,661 | -5,699 | -5,731 | -3,901 | -3,722 | -4,003 |
Cashflow From Financing | 10.7% | -6,078 | -6,806 | -5,656 | -4,124 | -4,810 | -4,126 | -6,655 | -6,665 | -3,907 | -6,672 | -4,677 | -5,471 | -7,957 | -3,096 | -1,771 | -1,622 | 403 | -1,248 | -3,075 | -2,727 | -1,435 |
Dividend Payments | 0.6% | 655 | 651 | 653 | 645 | 636 | 632 | 624 | 476 | 325 | 170 | 153 | 289 | 425 | 561 | 550 | 535 | 520 | 505 | 487 | 488 | 490 |
Buy Backs | -30.6% | 3,990 | 5,748 | 7,000 | 7,553 | 9,184 | 8,789 | 8,215 | 6,143 | 3,814 | 1,527 | 441 | 713 | 952 | 1,194 | 1,031 | 1,094 | 1,157 | 1,385 | 1,530 | 1,771 | 1,978 |
Condensed Consolidated Income Statements (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenues | $ 15,861 | $ 14,820 | $ 31,452 | $ 29,765 |
Salaries and benefits | 7,277 | 6,792 | 14,361 | 13,731 |
Supplies | 2,478 | 2,301 | 4,901 | 4,622 |
Other operating expenses | 3,043 | 2,693 | 5,937 | 5,445 |
Equity in losses (earnings) of affiliates | 7 | (8) | 25 | (19) |
Depreciation and amortization | 763 | 738 | 1,519 | 1,470 |
Interest expense | 485 | 434 | 964 | 842 |
Losses (gains) on sales of facilities | (1) | 32 | 14 | 22 |
Losses on retirement of debt | 0 | 78 | 0 | 78 |
Total expenses including equity in earnings of affiliates | 14,052 | 13,060 | 27,721 | 26,191 |
Income before income taxes | 1,809 | 1,760 | 3,731 | 3,574 |
Provision for income taxes | 397 | 381 | 776 | 730 |
Net income | 1,412 | 1,379 | 2,955 | 2,844 |
Net income attributable to noncontrolling interests | 219 | 224 | 399 | 416 |
Net income attributable to HCA Healthcare, Inc. | $ 1,193 | $ 1,155 | $ 2,556 | $ 2,428 |
Per share data: | ||||
Basic earnings | $ 4.35 | $ 3.95 | $ 9.27 | $ 8.16 |
Diluted earnings | $ 4.29 | $ 3.9 | $ 9.14 | $ 8.05 |
Shares used in earnings per share calculations (in millions): | ||||
Basic | 274,494 | 292,527 | 275,695 | 297,459 |
Diluted | 278,198 | 296,061 | 279,573 | 301,690 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 862 | $ 908 |
Accounts receivable | 8,713 | 8,891 |
Inventories | 2,050 | 2,068 |
Other | 2,263 | 1,776 |
Total current assets | 13,888 | 13,643 |
Property and equipment, at cost | 56,667 | 54,757 |
Accumulated depreciation | (30,023) | (29,182) |
Property and equipment, net | 26,644 | 25,575 |
Investments of insurance subsidiaries | 384 | 381 |
Investments in and advances to affiliates | 731 | 823 |
Goodwill and other intangible assets | 9,641 | 9,653 |
Right-of-use operating lease assets | 2,110 | 2,065 |
Other | 196 | 298 |
Total assets | 53,594 | 52,438 |
Current liabilities: | ||
Accounts payable | 3,823 | 4,239 |
Accrued salaries | 1,776 | 1,712 |
Other accrued expenses | 3,551 | 3,581 |
Long-term debt due within one year | 2,395 | 370 |
Total current liabilities | 11,545 | 9,902 |
Long-term debt, less debt issuance costs and discounts of $349 and $301 | 36,537 | 37,714 |
Professional liability risks | 1,554 | 1,528 |
Right-of-use operating lease obligations | 1,806 | 1,752 |
Income taxes and other liabilities | 1,691 | 1,615 |
Stockholders' equity (deficit): | ||
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares - 2023 and 277,378,300 shares - 2022 | 3 | 3 |
Accumulated other comprehensive loss | (456) | (490) |
Retained deficit | (1,850) | (2,280) |
Stockholders' deficit attributable to HCA Healthcare, Inc. | (2,303) | (2,767) |
Noncontrolling interests | 2,764 | 2,694 |
Total stockholders' equity | 461 | (73) |
Total liabilities and stockholders' equity | $ 53,594 | $ 52,438 |